This inventor holds 2 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent. Top assignees: Kymera Therapeutics, Inc., Odyssey Therapeutics, Inc.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Robert Aversa: Innovator in Medical Research
Introduction
Robert Aversa is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for various diseases. With a total of 2 patents, Aversa's work focuses on addressing critical health challenges.
Latest Patents
Aversa's latest patents include "Inhibitors of RIPK2 and medical uses thereof." This patent relates to RIPK2 inhibitors represented by a specific structural formula. The disclosure further encompasses pharmaceutical compositions comprising these inhibitors and methods for treating conditions such as inflammatory diseases, autoimmune diseases, granulomatous disease, neurodegenerative diseases, and cancer. Another significant patent is "CDK2 degraders and uses thereof," which provides compounds, compositions, and methods for utilizing these innovations in medical applications.
Career Highlights
Throughout his career, Robert Aversa has worked with prominent companies in the biotechnology sector. He has been associated with Kymera Therapeutics, Inc. and Odyssey Therapeutics, Inc., where he has contributed to advancing medical research and developing new therapeutic solutions.
Collaborations
Aversa has collaborated with talented individuals in his field, including Xiao Zhu and Shifeng Pan. These partnerships have played a crucial role in enhancing the scope and impact of his research.
Conclusion
Robert Aversa's innovative work in medical research and his contributions to the development of new treatments highlight his importance as an inventor. His patents reflect a commitment to addressing significant health issues through scientific advancement.